Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysfunction of Cellular Proteostasis in Parkinson’s Disease
Šárka Lehtonen, Tuuli-Maria Sonninen, Sara Wojciechowski, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 121

Showing 26-50 of 121 citing articles:

The effects of caloric restriction and its mimetics in Alzheimer's disease through autophagy pathways
Yi Yang, Lihui Zhang
Food & Function (2020) Vol. 11, Iss. 2, pp. 1211-1224
Closed Access | Times Cited: 47
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Tuuli-Maria Sonninen, Gundars Goldsteins, Nihay Laham-Karam, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2183-2183
Open Access | Times Cited: 43
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Manuela Gries, Anne Christmann, Steven Schulte, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 37
Super-resolution imaging reveals α-synuclein seeded aggregation in SH-SY5Y cells
Jason C. Sang, Eric Hidari, Georg Meisl, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 36
COVID-19 and Parkinson’s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia
Harini Sri Rethinavel, Sowbarnika Ravichandran, Risna Kanjirassery Radhakrishnan, et al.
Journal of Chemical Neuroanatomy (2021) Vol. 115, pp. 101965-101965
Open Access | Times Cited: 33
Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 25
Role of platelet in Parkinson’s disease: Insights into pathophysiology & theranostic solutions
Samir Kumar Beura, Abhishek Panigrahi, Pooja Yadav, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101681-101681
Closed Access | Times Cited: 23
Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment
Suganiya Umapathy, Ieshita Pan, Praveen Kumar Issac, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Control of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges
Daria Sicari, Aeid Igbaria, Éric Chevet
Cells (2019) Vol. 8, Iss. 11, pp. 1347-1347
Open Access | Times Cited: 41
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease
Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 17, pp. 2728-2740
Open Access | Times Cited: 39
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Carolina Sportelli, Daniele Urso, Peter Jenner, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 37
Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
Luke McAlary, Yee Lian Chew, Jeremy S. Lum, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 37
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Maxime Teixeira, Razan Sheta, Walid Idi, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1333-1333
Open Access | Times Cited: 31
Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
Francisco J. Padilla-Godínez, L.I. Ruiz-Ortega, Magdalena Guerra‐Crespo
Cells (2022) Vol. 11, Iss. 21, pp. 3445-3445
Open Access | Times Cited: 20
Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
Carmela Conte, Angela Ingrassia, John J. P. Brevé, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1368-1368
Open Access | Times Cited: 12
Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
Fiona Dick, Ole‐Bjørn Tysnes, Guido Alves, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105925-105925
Open Access | Times Cited: 11
Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
Fahad Mubariz, Afsoon Saadin, Nicholas Lingenfelter, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
Aliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7102-7102
Open Access | Times Cited: 4
From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches
Negar Ebadpour, Mahmoud Mahmoudi, Ramiar Kamal Kheder, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113015-113015
Closed Access | Times Cited: 4
USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells
Vignesh Srinivasan, Rabah Soliymani, Larisa Ivanova, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42031-e42031
Open Access
Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson’s Disease
Samantha Edwards, Frances Corrigan, Lyndsey E. Collins‐Praino
Molecular Neurobiology (2025)
Open Access
The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells
Natasja Deshayes, Sertan Arkan, Christian Hansen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4495-4495
Open Access | Times Cited: 35
Genetic networks in Parkinson’s and Alzheimer’s disease
Jack Kelly, Rana Moyeed, Camille Carroll, et al.
Aging (2020) Vol. 12, Iss. 6, pp. 5221-5243
Open Access | Times Cited: 32
Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis
Ashish Singh, Arun Kumar Yadawa, Swati Chaturvedi, et al.
Food and Chemical Toxicology (2021) Vol. 155, pp. 112433-112433
Closed Access | Times Cited: 24

Scroll to top